USA: Postdoctoral Scholars: Translational Research in Neuropharmacology--Dopamine/Melatonin Receptors and Circadian Rhythms, Northwestern University
One of the top-ranked universities in the country, Northwestern University combines innovative teaching and pioneering research in a highly collaborative environment that transcends traditional academic boundaries. Northwestern provides students, faculty, and staff with exceptional opportunities for intellectual, personal, and professional growth. A postdoctoral research position supported by NIH funding is available immediately for a Ph.D. or MD/Ph.D. to work on research into the role of MT1 and MT2 melatonin receptors in the modulation of dopaminergic sensitization and circadian alterations following repetitive treatment with drugs of abuse (e.g., methamphetamine).
Projects include the use of mouse models with genetic deletion of the MT1 and/or MT2 melatonin receptors and/or clock genes, and the identification of novel drugs for the treatment of insomnia, depression, and circadian sleep disorders induced by drugs of abuse. Preference will be given to candidates with strong research backgrounds and practical experience with mammalian clock gene expression, circadian rhythms of behavior, and brain surgical procedures. Knowledge of electrophysiological techniques and the molecular neuropharmacology of G-protein coupled receptors is also desired. Candidates should be willing to use integrated circadian in vitro and in vivo approaches to assess the role of drugs of abuse on clock gene expression and circadian behaviors. This position represents a unique opportunity for career development, for learning the neuropharmacology of circadian rhythms and drug discovery, and for interactions with investigators within the multidisciplinary scientific community at Northwestern University.
Applications should include a cover letter summarizing career experiences and specific qualifications, a CV, and full contact information for at least 3 references. Submit applications directly Dr. Margarita L. Dubocovich [mdubo@northwestern.edu; (312) 503-8005]. Deadline for receipt of completed applications is August 15, 2007. AA/EOE. We encourage applications from women and members of underrepresented groups.
Contact Dr. Margarita L. Dubocovich:
E-mail: mdubo@northwestern.edu
Phone: (312) 503-8005
Fax: (312) 503-2334
Application Deadline: 15-Aug-07
Projects include the use of mouse models with genetic deletion of the MT1 and/or MT2 melatonin receptors and/or clock genes, and the identification of novel drugs for the treatment of insomnia, depression, and circadian sleep disorders induced by drugs of abuse. Preference will be given to candidates with strong research backgrounds and practical experience with mammalian clock gene expression, circadian rhythms of behavior, and brain surgical procedures. Knowledge of electrophysiological techniques and the molecular neuropharmacology of G-protein coupled receptors is also desired. Candidates should be willing to use integrated circadian in vitro and in vivo approaches to assess the role of drugs of abuse on clock gene expression and circadian behaviors. This position represents a unique opportunity for career development, for learning the neuropharmacology of circadian rhythms and drug discovery, and for interactions with investigators within the multidisciplinary scientific community at Northwestern University.
Applications should include a cover letter summarizing career experiences and specific qualifications, a CV, and full contact information for at least 3 references. Submit applications directly Dr. Margarita L. Dubocovich [mdubo@northwestern.edu; (312) 503-8005]. Deadline for receipt of completed applications is August 15, 2007. AA/EOE. We encourage applications from women and members of underrepresented groups.
Contact Dr. Margarita L. Dubocovich:
E-mail: mdubo@northwestern.edu
Phone: (312) 503-8005
Fax: (312) 503-2334
Application Deadline: 15-Aug-07
Comments